Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis
Introduction: Current therapeutic management of lupus nephritis (LN) fails to induce long-term remission in over 50% of patients, highlighting the urgent need for additional options. Methods: We analyzed differentially expressed genes (DEGs) in peripheral blood from patients with active LN (n = 41)...
Saved in:
Similar Items
-
Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosus
by: Julius Lindblom, et al.
Published: (2025-12-01) -
Lupus discoide en niños y adultos: ¿cuál es la diferencia?
by: Alba Patricia Ferrín, et al.
Published: (2019-08-01) -
A Rare Case of Lupus Nephritis with Predominant Gastrointestinal Manifestation: A Case Study
by: Jasmine Podimon, et al.
Published: (2024-12-01) -
Lupus eritematoso cutáneo crónico
by: Andres Vidal C.
Published: (2004-12-01) -
Lupus nephritis – modern aspects of diagnosis and therapy. Part I
by: S. K. Solovyev, et al.
Published: (2024-03-01)